David BALAYSSAC (EN)

Research Theme:

  • Study of the pathophysiology of CIPN, and the effectiveness of new therapeutic strategies (animal and humans)
  • Study of non-invasive circulating biomarkers of CIPN (animal and humans)
  • Study of the epidemiology of pain and comorbidities during and after cancer (Male)

Teachings:

  • Head of the Units of Specialized Toxicology, Oncology, and Disorders linked to the use of psychoactive substances and doping, DFASP1, UFR of Pharmacy
  • Head of the Oncology Unit at the pharmacy , 6th year of Pharmacy, UFR of Pharmacy
  • Supervision of 2 PhDs
  • Supervision of 12 Masters

Responsibilities:

  • Vice-Dean-Director, UFR of Pharmacy
  • Head of the Toxicology educational service, UFR of Pharmacy
  • Responsible for international relations, UFR of Pharmacy
  • Head of the 2nd cycle of Pharmacy studies, UFR of Pharmacy
  • Member of the Specialized Scientific Commission Neuroscience (CSS4)
  • Expert member of the High Council for the Evaluation of research and higher education (HCERES), pedagogy
  • Former member of the National Council of Universities (CNU) 81

Recent article selections:

  • Ragusa et al. Study of the relationship between psychoactive substance use and pain in cancer patients and cancer survivors: A French nationwide cross-sectional study. Int J Cancer. 2024 doi: 10.1002/ijc.35006.
  • Balayssac et al. Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel – NeuroDeRisk project. Biomed Pharmacother. 2023. doi: 10.1016/j.biopha.2023.115535.
  • Selvy et al. Analgesic and preventive effects of donepezil in animal models of chemotherapy-induced peripheral neuropathy: Involvement of spinal muscarinic acetylcholine M2 receptors. Biomed Pharmacother. 2022. doi: 10.1016/j.biopha.2022.112915.
  • Selvy et al. Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study. Front Pharmacol. 2021. doi: 10.3389/fphar.2021.637593.
  • Selvy M et al. Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists’ professional practices. Support Care Cancer. 2021. doi: 10.1007/s00520-020-05928-6.
  • Selvy et al. Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study. J Clin Med. 2020. doi: 10.3390/jcm9082400.
  • Ferrier et al. Cholinergic Neurotransmission in the Posterior Insular Cortex Is Altered in Preclinical Models of Neuropathic Pain: Key Role of Muscarinic M2 Receptors in Donepezil-Induced Antinociception. J Neurosci. 2015. doi: 10.1523/JNEUROSCI.1537-15.2015.

Additional Information:

ORCID : 0000-0002-6126-6588
Linkedin : David Balayssac

HAL Publications